Your browser is no longer supported. Please, upgrade your browser.
Settings
A [NYSE]
Agilent Technologies, Inc.
IndexS&P 500 P/E51.28 EPS (ttm)2.98 Insider Own0.30% Shs Outstand304.00M Perf Week1.88%
Market Cap46.28B Forward P/E33.12 EPS next Y4.62 Insider Trans-20.01% Shs Float301.33M Perf Month3.57%
Income925.00M PEG4.75 EPS next Q0.99 Inst Own89.50% Short Float0.85% Perf Quarter14.93%
Sales5.82B P/S7.96 EPS this Y-31.60% Inst Trans0.35% Short Ratio1.53 Perf Half Y26.68%
Book/sh15.82 P/B9.68 EPS next Y11.62% ROA9.40% Target Price148.94 Perf Year58.90%
Cash/sh4.56 P/C33.53 EPS next 5Y10.80% ROE19.00% 52W Range94.53 - 153.60 Perf YTD29.18%
Dividend0.78 P/FCF45.19 EPS past 5Y12.00% ROI10.00% 52W High-0.35% Beta1.00
Dividend %0.51% Quick Ratio1.50 Sales past 5Y5.70% Gross Margin53.50% 52W Low61.94% ATR1.85
Employees16500 Current Ratio2.00 Sales Q/Q23.20% Oper. Margin19.70% RSI (14)67.06 Volatility1.19% 1.17%
OptionableYes Debt/Eq0.61 EPS Q/Q117.30% Profit Margin15.90% Rel Volume0.85 Prev Close153.23
ShortableYes LT Debt/Eq0.57 EarningsAug 17 AMC Payout24.40% Avg Volume1.68M Price153.07
Recom1.90 SMA202.13% SMA505.72% SMA20020.40% Volume1,430,347 Change-0.10%
Mar-18-21Upgrade Citigroup Neutral → Buy $135 → $150
Feb-17-21Upgrade BofA Securities Neutral → Buy $147
Dec-02-20Initiated Goldman Buy $130
Nov-25-20Upgrade UBS Neutral → Buy $103 → $132
Nov-17-20Upgrade Cleveland Research Neutral → Buy
Nov-10-20Initiated KeyBanc Capital Markets Overweight $130
Sep-30-20Initiated Atlantic Equities Neutral $105
Aug-19-20Reiterated Wells Fargo Overweight $100 → $105
Aug-19-20Reiterated SVB Leerink Outperform $95 → $100
Aug-19-20Reiterated Stifel Hold $85 → $100
Aug-19-20Reiterated Robert W. Baird Outperform $87 → $104
Aug-19-20Reiterated Jefferies Buy $95 → $110
Aug-19-20Reiterated Citigroup Neutral $85 → $100
Aug-19-20Reiterated BofA Securities Neutral $99 → $103
Feb-24-20Downgrade Needham Buy → Hold
Jan-08-20Initiated Wells Fargo Overweight $100
Jan-07-20Initiated Citigroup Neutral $85
Nov-26-19Reiterated Needham Buy $92 → $85
Nov-15-19Initiated Stifel Hold
Oct-18-19Downgrade UBS Buy → Neutral $82
Aug-02-21 12:54PM  
12:10PM  
12:00PM  
11:27AM  
10:08AM  
09:32AM  
08:50AM  
Jul-30-21 12:02PM  
11:45AM  
11:42AM  
11:05AM  
11:05AM  
10:27AM  
10:00AM  
09:30AM  
Jul-29-21 11:59AM  
11:53AM  
11:30AM  
Jul-28-21 09:37AM  
08:00AM  
Jul-27-21 11:36AM  
10:58AM  
08:00AM  
Jul-26-21 11:45AM  
11:37AM  
Jul-22-21 11:00AM  
Jul-21-21 10:44AM  
08:00AM  
Jul-20-21 12:34PM  
08:30AM  
Jul-19-21 09:00AM  
Jul-15-21 10:41AM  
Jul-13-21 09:00AM  
Jul-09-21 11:09AM  
01:17AM  
Jul-05-21 12:00PM  
10:28AM  
Jul-01-21 09:00AM  
Jun-28-21 08:00AM  
Jun-24-21 11:30AM  
Jun-23-21 01:25PM  
10:15AM  
Jun-22-21 03:00AM  
Jun-18-21 11:01AM  
08:47AM  
Jun-17-21 11:30AM  
Jun-14-21 12:20PM  
08:00AM  
Jun-09-21 01:19AM  
Jun-04-21 02:18PM  
08:00AM  
Jun-03-21 12:00PM  
Jun-02-21 08:00AM  
Jun-01-21 08:00AM  
May-26-21 10:00AM  
08:27AM  
May-25-21 08:30PM  
05:20PM  
04:05PM  
May-20-21 01:37PM  
01:12PM  
May-19-21 04:05PM  
May-18-21 03:00PM  
08:30AM  
May-13-21 12:29PM  
09:44AM  
May-12-21 10:49AM  
May-11-21 01:53PM  
11:55AM  
11:00AM  
May-10-21 02:44PM  
12:01PM  
10:22AM  
10:09AM  
09:58AM  
08:42AM  
06:42AM  
06:38AM  
May-07-21 04:11PM  
01:08PM  
01:06PM  
01:03PM  
10:48AM  
10:07AM  
10:02AM  
09:59AM  
09:44AM  
09:00AM  
08:24AM  
07:32AM  
May-06-21 03:55PM  
03:51PM  
12:42PM  
12:04PM  
12:01PM  
12:00PM  
11:28AM  
11:12AM  
11:06AM  
10:46AM  
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment to produce synthesized oligonucleotide. It also offers immunohistochemistry, in situ hybridization, and hematoxylin and eosin staining and special staining; instruments, consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was incorporated in 1999 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grau DominiqueSenior Vice PresidentJun 17Option Exercise40.801,96880,29483,388Jun 21 05:18 PM
Grau DominiqueSenior Vice PresidentJun 17Sale145.101,968285,56381,420Jun 21 05:18 PM
Grau DominiqueSenior Vice PresidentJun 16Option Exercise40.803,487142,27084,907Jun 17 12:16 PM
Grau DominiqueSenior Vice PresidentJun 16Sale145.013,487505,65381,420Jun 17 12:16 PM
Grau DominiqueSenior Vice PresidentJun 15Option Exercise40.803,578145,98284,998Jun 17 12:16 PM
Grau DominiqueSenior Vice PresidentJun 15Sale145.033,578518,91781,420Jun 17 12:16 PM
Ancher-Jensen HenrikSr Vice PresidentJun 14Option Exercise40.8024,8411,013,513120,633Jun 17 12:13 PM
Ancher-Jensen HenrikSr Vice PresidentJun 14Sale143.6643,7316,282,52776,902Jun 17 12:13 PM
Thaysen JacobSr. Vice PresidentJun 10Sale142.9016,2892,327,69883,423Jun 14 12:18 PM
MCDONNELL PADRAIGSr. Vice PresidentMay 28Sale138.421,000138,42016,916Jun 01 06:19 PM
Tang MichaelSVP, General Counsel, and Sec.May 27Sale136.1513,4651,833,35139,579Jun 01 06:18 PM
Tang MichaelSVP, General Counsel, and Sec.Apr 23Sale137.0050068,50053,030Apr 26 05:59 PM
McMullen Michael R.CEO and PresidentApr 22Sale135.009,0531,222,155261,105Apr 26 05:58 PM
McMullen Michael R.CEO and PresidentApr 13Sale132.508,9661,187,995270,158Apr 15 06:47 PM
McMullen Michael R.CEO and PresidentApr 08Sale130.2615,0951,966,275279,124Apr 12 07:01 PM
Gonsalves RodneyV.P., Corporate ControllerFeb 22Sale124.175,000620,85041,229Feb 24 05:54 PM
Grau DominiqueSenior Vice PresidentFeb 17Option Exercise40.809,034368,58795,071Feb 18 06:31 PM
Tang MichaelSVP, General Counsel, and Sec.Feb 17Sale133.0050066,50053,530Feb 18 06:48 PM
Grau DominiqueSenior Vice PresidentFeb 17Sale135.1113,7451,857,08781,326Feb 18 06:31 PM
Grau DominiqueSenior Vice PresidentFeb 16Sale130.146,041786,19486,037Feb 18 06:31 PM
Tang MichaelSVP, General Counsel, and Sec.Feb 16Sale129.3150064,65554,030Feb 18 06:48 PM
McMullen Michael R.CEO and PresidentFeb 16Sale130.0020,7662,699,580294,219Feb 18 06:33 PM
McMullen Michael R.CEO and PresidentFeb 02Sale123.7441,9785,194,232314,985Feb 03 01:28 PM
McMullen Michael R.CEO and PresidentFeb 01Sale120.2621,2122,550,955356,963Feb 03 01:28 PM
Tang MichaelSVP, General Counsel, and Sec.Jan 14Sale127.2750063,63554,880Jan 19 05:01 PM
McMullen Michael R.CEO and PresidentDec 01Sale115.6385,8429,925,910415,347Dec 02 08:17 PM
KOH BOON HWEEDirectorNov 30Sale114.5120,0002,290,20068,051Dec 02 08:16 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 09Sale116.162,222258,10856,807Nov 12 01:31 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 05Sale111.001,111123,32159,029Nov 09 02:33 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 04Sale108.501,111120,54460,140Nov 05 03:45 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 03Sale106.431,111118,24461,251Nov 05 03:45 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 02Sale103.521,111115,01162,362Nov 03 03:41 PM
Tang MichaelSVP, General Counsel, and Sec.Oct 30Sale101.773,333339,19963,473Nov 03 03:41 PM
Grau DominiqueSenior Vice PresidentOct 09Option Exercise39.126,485253,693104,154Oct 13 02:32 PM
Grau DominiqueSenior Vice PresidentOct 09Sale105.006,485680,92597,669Oct 13 02:32 PM
Grau DominiqueSenior Vice PresidentAug 31Option Exercise39.126,485253,693104,154Sep 01 05:19 PM
Grau DominiqueSenior Vice PresidentAug 31Sale100.006,485648,50097,669Sep 01 05:19 PM
Gonsalves RodneyV.P., Corporate ControllerAug 25Option Exercise40.806,191252,59348,334Aug 27 12:15 PM
Gonsalves RodneyV.P., Corporate ControllerAug 25Sale98.176,191607,75242,143Aug 27 12:15 PM
AA Alcoa Corporation daily Stock Chart
AA [NYSE]
Alcoa Corporation
Index- P/E17.39 EPS (ttm)2.27 Insider Own0.60% Shs Outstand187.00M Perf Week1.13%
Market Cap7.21B Forward P/E8.32 EPS next Y4.74 Insider Trans-23.27% Shs Float184.93M Perf Month6.60%
Income431.00M PEG- EPS next Q1.36 Inst Own81.90% Short Float6.18% Perf Quarter4.76%
Sales10.46B P/S0.69 EPS this Y85.00% Inst Trans0.90% Short Ratio1.48 Perf Half Y109.35%
Book/sh20.16 P/B1.95 EPS next Y-2.61% ROA2.90% Target Price42.55 Perf Year203.08%
Cash/sh9.02 P/C4.37 EPS next 5Y- ROE12.60% 52W Range10.98 - 44.42 Perf YTD70.93%
Dividend- P/FCF- EPS past 5Y28.00% ROI5.60% 52W High-11.30% Beta2.70
Dividend %- Quick Ratio1.00 Sales past 5Y-3.70% Gross Margin19.10% 52W Low258.83% ATR1.82
Employees12900 Current Ratio1.60 Sales Q/Q31.90% Oper. Margin9.40% RSI (14)58.96 Volatility3.85% 5.11%
OptionableYes Debt/Eq0.59 EPS Q/Q253.60% Profit Margin4.10% Rel Volume0.98 Prev Close40.15
ShortableYes LT Debt/Eq0.59 EarningsJul 15 AMC Payout0.00% Avg Volume7.71M Price39.40
Recom2.40 SMA207.67% SMA507.40% SMA20040.54% Volume7,586,818 Change-1.87%
Jul-16-21Upgrade Citigroup Neutral → Buy $52
Apr-23-21Resumed JP Morgan Overweight $28 → $39
Mar-24-21Upgrade Morgan Stanley Equal-Weight → Overweight $43
Mar-17-21Upgrade Deutsche Bank Hold → Buy $36
Mar-03-21Upgrade Goldman Sell → Buy $19 → $32
Sep-08-20Upgrade BofA Securities Neutral → Buy
Jun-16-20Downgrade Deutsche Bank Buy → Hold $10
Mar-24-20Downgrade B. Riley FBR Buy → Neutral $21 → $7
Mar-04-20Upgrade BofA/Merrill Underperform → Neutral $20 → $15
Jan-17-20Upgrade Deutsche Bank Hold → Buy $21.50 → $20.50
Dec-17-19Downgrade BMO Capital Markets Outperform → Market Perform
Nov-13-19Downgrade BofA/Merrill Neutral → Underperform $21
Nov-12-19Reiterated B. Riley FBR Buy $26 → $28
Nov-07-19Resumed Morgan Stanley Equal-Weight $25
Oct-21-19Downgrade Gabelli & Co Buy → Hold
Sep-26-19Reiterated B. Riley FBR Buy $34 → $27
Sep-23-19Downgrade Goldman Buy → Neutral $30 → $25
Sep-11-19Upgrade Credit Suisse Neutral → Outperform $26 → $27
Aug-16-19Reiterated BofA/Merrill Neutral $25 → $20
Jul-19-19Downgrade Argus Buy → Hold
Jul-25-21 09:00PM  
Jul-23-21 10:36AM  
Jul-22-21 04:26PM  
Jul-20-21 03:22PM  
Jul-19-21 04:12AM  
Jul-17-21 03:01AM  
Jul-16-21 02:02PM  
11:50AM  
03:59AM  
Jul-15-21 09:30PM  
05:25PM  
04:47PM  
04:31PM  
04:10PM  
01:39PM  
Jul-14-21 08:50AM  
Jul-13-21 09:45AM  
09:16AM  
Jul-12-21 11:30AM  
08:50AM  
Jul-08-21 03:00PM  
08:30AM  
Jul-05-21 12:10PM  
Jul-01-21 05:45PM  
Jun-29-21 10:19AM  
08:38AM  
Jun-28-21 08:29AM  
08:20AM  
07:34AM  
07:15AM  
Jun-25-21 05:45PM  
11:30AM  
07:13AM  
Jun-24-21 04:10PM  
Jun-23-21 08:50AM  
06:02AM  
Jun-18-21 01:11AM  
Jun-17-21 07:44AM  
02:12AM  
Jun-16-21 08:29AM  
08:16AM  
07:10AM  
Jun-11-21 03:15AM  
Jun-10-21 05:45PM  
Jun-09-21 11:30AM  
09:33AM  
Jun-04-21 05:45PM  
Jun-02-21 04:10PM  
01:19AM  
May-31-21 06:20AM  
May-28-21 05:45PM  
08:36AM  
May-24-21 11:30AM  
May-20-21 11:25PM  
01:02PM  
09:00AM  
May-18-21 08:51AM  
May-11-21 04:10PM  
May-10-21 09:32AM  
May-07-21 11:30AM  
08:26AM  
May-06-21 12:47PM  
09:56AM  
09:35AM  
May-05-21 05:45PM  
10:18AM  
08:30AM  
May-04-21 09:25AM  
08:00AM  
07:52AM  
May-03-21 10:12AM  
Apr-30-21 09:37AM  
Apr-29-21 12:54PM  
09:52AM  
09:41AM  
Apr-28-21 09:16AM  
09:05AM  
Apr-26-21 12:00PM  
08:12AM  
Apr-22-21 01:01PM  
Apr-20-21 08:05AM  
Apr-19-21 11:30AM  
09:44AM  
08:34AM  
03:12AM  
Apr-17-21 03:04AM  
Apr-16-21 05:32PM  
03:53PM  
10:19AM  
Apr-15-21 10:30PM  
07:11PM  
05:34PM  
05:25PM  
04:10PM  
02:15PM  
09:06AM  
07:05AM  
Apr-14-21 04:22PM  
08:40AM  
06:48AM  
Alcoa Corporation, together with its subsidiaries, produces and sells bauxite, alumina, and aluminum products in the United States, Spain, Australia, Brazil, Canada, and internationally. The company operates through three segments: Bauxite, Alumina, and Aluminum. It engages in bauxite mining operations; and processes bauxite into alumina and sells it to customers who process it into industrial chemical products, as well as aluminum smelting, casting, and rolling businesses. The company offers primary aluminum in the form of alloy ingot or value-add ingot to customers that produce products for the transportation, building and construction, packaging, wire, and other industrial markets; and flat-rolled aluminum sheets to customers that produce beverage and food cans. In addition, it owns hydro power plants that produce and sell electricity to the wholesale market to traders, large industrial consumers, distribution companies, and other generation companies. The company was formerly known as Alcoa Upstream Corporation and changed its name to Alcoa Corporation in October 2016. The company was founded in 1888 and is headquartered in Pittsburgh, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heeter Jeffrey D.EVP & Gen. CounselJun 01Sale40.5323,089935,87358,599Jun 03 04:17 PM
Jones Tammi AEVP & CHROMay 07Option Exercise36.424,435161,54511,185May 10 04:22 PM
Kahrs Benjamin DEVP & Chief Innovation OfficerMay 07Option Exercise15.1016,574250,26756,712May 10 04:25 PM
Kahrs Benjamin DEVP & Chief Innovation OfficerMay 07Sale39.6828,0821,114,35828,630May 10 04:25 PM
Jones Tammi AEVP & CHROMay 07Sale41.184,435182,6486,750May 10 04:22 PM
Reyes Timothy D.EVP & Chief Commercial OfficerApr 26Option Exercise27.9612,260342,79091,091Apr 28 04:30 PM
Reyes Timothy D.EVP & Chief Commercial OfficerApr 26Sale36.8220,260745,90470,831Apr 28 04:30 PM
Harvey Roy ChristopherPresident, CEO & DirectorApr 20Option Exercise22.68238,0375,398,873767,709Apr 22 04:18 PM
Heeter Jeffrey D.EVP & Gen. CounselApr 20Option Exercise27.9612,260342,79093,948Apr 22 04:22 PM
Harvey Roy ChristopherPresident, CEO & DirectorApr 20Sale32.91238,0377,834,060529,672Apr 22 04:18 PM
Heeter Jeffrey D.EVP & Gen. CounselApr 20Sale35.3512,260433,42481,688Apr 22 04:22 PM
Jones Tammi AEVP & CHROMar 10Option Exercise18.524,21478,05110,964Mar 12 04:19 PM
Jones Tammi AEVP & CHROMar 10Sale31.914,214134,4676,750Mar 12 04:19 PM
Jones Tammi AEVP & CHROMar 10Sale31.892,73187,08643,562Mar 12 04:19 PM
Nevels James EDirectorJan 27Buy17.504007,00032,336Jan 28 05:30 PM
Jones Tammi AEVP & CHRODec 02Sale21.181,50031,7773,750Dec 04 04:27 PM
Nevels James EDirectorNov 17Buy17.292003,45831,936Nov 18 05:00 PM
Nevels James EDirectorOct 19Buy12.752002,55031,736Oct 20 04:23 PM
Nevels James EDirectorSep 17Buy13.302002,66028,972Sep 18 04:28 PM
Nevels James EDirectorAug 17Buy14.722002,94528,772Aug 18 04:19 PM
AAP Advance Auto Parts, Inc. daily Stock Chart
AAP [NYSE]
Advance Auto Parts, Inc.
IndexS&P 500 P/E22.80 EPS (ttm)9.33 Insider Own0.40% Shs Outstand65.69M Perf Week-0.64%
Market Cap14.01B Forward P/E17.26 EPS next Y12.32 Insider Trans-1.05% Shs Float65.16M Perf Month1.80%
Income635.40M PEG1.66 EPS next Q3.02 Inst Own- Short Float5.28% Perf Quarter5.38%
Sales10.74B P/S1.30 EPS this Y4.40% Inst Trans0.51% Short Ratio4.53 Perf Half Y40.90%
Book/sh53.31 P/B3.99 EPS next Y11.66% ROA5.30% Target Price218.69 Perf Year41.67%
Cash/sh13.37 P/C15.91 EPS next 5Y13.70% ROE17.50% 52W Range142.46 - 217.69 Perf YTD35.05%
Dividend4.00 P/FCF14.51 EPS past 5Y2.20% ROI11.80% 52W High-2.29% Beta1.38
Dividend %1.88% Quick Ratio0.40 Sales past 5Y0.70% Gross Margin44.70% 52W Low49.31% ATR3.69
Employees40000 Current Ratio1.30 Sales Q/Q23.40% Oper. Margin8.20% RSI (14)57.70 Volatility1.86% 1.75%
OptionableYes Debt/Eq0.00 EPS Q/Q347.80% Profit Margin5.90% Rel Volume0.67 Prev Close212.06
ShortableYes LT Debt/Eq0.30 EarningsJun 02 BMO Payout10.70% Avg Volume759.90K Price212.71
Recom2.20 SMA200.95% SMA505.12% SMA20019.91% Volume509,353 Change0.31%
Jul-27-21Upgrade Raymond James Outperform → Strong Buy $215 → $250
May-19-21Resumed Credit Suisse Outperform $215
May-04-21Upgrade Goldman Sell → Buy $180 → $227
Mar-09-21Initiated Citigroup Buy $193
Feb-23-21Upgrade Atlantic Equities Underweight → Neutral $175
Oct-21-20Upgrade Raymond James Mkt Perform → Outperform $175
Oct-06-20Upgrade JP Morgan Neutral → Overweight $183 → $190
Oct-05-20Initiated Exane BNP Paribas Underperform
Aug-14-20Initiated DA Davidson Neutral
Jun-15-20Downgrade Atlantic Equities Neutral → Underweight $118
May-20-20Reiterated Wedbush Outperform $120 → $150
Apr-21-20Upgrade Guggenheim Neutral → Buy $153
Jan-23-20Downgrade Atlantic Equities Overweight → Neutral $159
Jan-13-20Downgrade JP Morgan Overweight → Neutral $168 → $163
Oct-08-19Resumed Raymond James Mkt Perform
Oct-08-19Downgrade Wolfe Research Outperform → Peer Perform
Sep-13-19Upgrade Citigroup Neutral → Buy
Aug-14-19Downgrade Guggenheim Buy → Neutral
Jul-11-19Initiated Goldman Sell $151
Mar-20-19Initiated Evercore ISI Outperform $185
Jul-28-21 09:00AM  
Jul-23-21 09:27AM  
Jul-14-21 09:23AM  
Jul-13-21 08:30AM  
Jul-08-21 01:18AM  
Jul-02-21 11:30AM  
10:45AM  
Jun-21-21 12:17PM  
Jun-12-21 03:01AM  
Jun-10-21 08:00AM  
Jun-08-21 03:17PM  
08:40AM  
Jun-03-21 05:12AM  
Jun-02-21 04:58PM  
03:52PM  
02:00PM  
10:51AM  
10:16AM  
09:46AM  
06:42AM  
06:30AM  
Jun-01-21 12:49PM  
May-30-21 02:56AM  
May-26-21 01:18AM  
May-24-21 08:37AM  
May-13-21 04:30PM  
May-12-21 07:00PM  
May-06-21 03:28PM  
May-05-21 03:04PM  
10:06AM  
May-04-21 10:46AM  
Apr-30-21 01:19AM  
Apr-29-21 08:00AM  
Apr-28-21 04:55AM  
Apr-26-21 12:53PM  
Apr-23-21 12:00PM  
Apr-22-21 12:00PM  
Apr-20-21 10:57AM  
07:00AM  
Apr-13-21 08:56AM  
Apr-12-21 05:25PM  
04:52PM  
04:43PM  
Apr-07-21 12:57PM  
Apr-04-21 11:42PM  
03:03AM  
Mar-25-21 08:25AM  
Mar-24-21 04:15PM  
08:00AM  
Mar-18-21 11:30AM  
Mar-17-21 12:44PM  
Mar-16-21 09:38AM  
Mar-15-21 04:30PM  
Mar-11-21 03:19PM  
Mar-10-21 09:35AM  
Mar-09-21 02:34PM  
09:48AM  
Mar-08-21 11:20PM  
Feb-16-21 02:00PM  
08:44AM  
06:30AM  
Feb-15-21 10:39AM  
Feb-14-21 03:00AM  
Feb-12-21 09:53AM  
Feb-11-21 11:16AM  
Feb-10-21 11:16PM  
Feb-09-21 12:30PM  
Feb-02-21 12:00PM  
Feb-01-21 05:00PM  
Jan-27-21 10:57AM  
Jan-25-21 12:10PM  
Jan-21-21 04:46PM  
Jan-05-21 09:04AM  
Jan-03-21 11:47AM  
Dec-16-20 10:18AM  
Dec-14-20 06:41PM  
Dec-10-20 11:30AM  
Dec-08-20 09:10AM  
Nov-27-20 08:28AM  
Nov-24-20 03:30PM  
Nov-19-20 08:00AM  
Nov-17-20 09:26AM  
Nov-16-20 08:45AM  
Nov-11-20 11:36AM  
10:05AM  
Nov-10-20 01:30PM  
10:13AM  
09:17AM  
07:45AM  
07:34AM  
06:30AM  
Nov-09-20 10:13AM  
10:12AM  
09:42AM  
08:47AM  
Nov-03-20 12:30PM  
Oct-28-20 12:16PM  
Oct-27-20 04:30PM  
09:00AM  
Oct-25-20 06:15AM  
Advance Auto Parts, Inc. provides automotive replacement parts, accessories, batteries, and maintenance items for domestic and imported cars, vans, sport utility vehicles, and light and heavy duty trucks. The company offers battery accessories; belts and hoses; brakes and brake pads; chassis and climate control parts; clutches and drive shafts; engines and engine parts; exhaust systems and parts; hub assemblies; ignition components and wires; radiators and cooling parts; starters and alternators; and steering and alignment parts. It also offers air conditioning chemicals and accessories; air fresheners; antifreeze and washer fluids; electrical wires and fuses; electronics; floor mats, seat covers, and interior accessories; hand and specialty tools; lighting products; performance parts; sealants, adhesives and compounds; tire repair accessories; vent shades, mirrors and exterior accessories; washes, waxes and cleaning supplies; and wiper blades. In addition, the company offers air filters; fuel and oil additives; fuel filters; grease and lubricants; motor oils; oil filters, part cleaners and treatments; and transmission fluids for engine maintenance. Further, it offers battery and wiper installation; engine light scanning and checking; electrical system testing; video clinic; oil and battery recycling; and loaner tool program services. Additionally, the company sells its products through its Website. It serves professional installers and do-it-yourself customers. The company operates stores under the Advance Auto Parts, Autopart International, and Carquest brands, as well as branches under the Worldpac name. As of January 2, 2021, it operated 4,806 stores and 170 branches in the United States, Puerto Rico, the U.S. Virgin Islands, and Canada; and served 1,277 independently owned Carquest branded stores in Mexico, Grand Cayman, the Bahamas, Turks and Caicos, and the British Virgin Islands. The company was founded in 1929 and is based in Raleigh, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bailo Carla JeanDirectorJun 16Buy197.8040079,1191,964Jun 21 10:35 AM
Schechtman NatalieEVP Human ResourcesJun 08Sale197.583,200632,2565,545Jun 09 06:10 PM
Schechtman NatalieEVP Human ResourcesMar 03Option Exercise162.663,081501,1559,108Mar 04 08:49 PM
Broderick Michael TEVP Merch & Store Ops SupportMar 03Option Exercise162.663,081501,1559,004Mar 04 08:47 PM
Greco ThomasPresident and CEOMar 03Option Exercise162.6625,6674,174,994159,268Mar 04 08:44 PM
Finley Tammy MEVP, General Counsel, Corp SecMar 03Option Exercise162.663,081501,15516,218Mar 04 08:41 PM
Cushing Robert BEVP, ProfessionalMar 03Option Exercise162.663,081501,15518,293Mar 04 08:38 PM
Shepherd Jeffrey WEVP, CFOMar 03Option Exercise162.661,787290,67312,150Mar 04 08:33 PM
Cushing Robert BEVP, ProfessionalJan 14Option Exercise123.3271187,68115,800Jan 19 08:09 AM
ABCL AbCellera Biologics Inc. daily Stock Chart
ABCL [NASD]
AbCellera Biologics Inc.
Index- P/E20.20 EPS (ttm)0.78 Insider Own21.00% Shs Outstand269.70M Perf Week2.79%
Market Cap4.41B Forward P/E- EPS next Y-0.00 Insider Trans-21.35% Shs Float182.99M Perf Month-23.05%
Income- PEG- EPS next Q0.11 Inst Own41.90% Short Float4.66% Perf Quarter-39.15%
Sales431.24M P/S10.23 EPS this Y415.00% Inst Trans12.07% Short Ratio4.92 Perf Half Y-70.26%
Book/sh3.55 P/B4.46 EPS next Y-100.00% ROA- Target Price- Perf Year-
Cash/sh2.46 P/C6.44 EPS next 5Y- ROE- 52W Range14.51 - 71.91 Perf YTD-60.69%
Dividend- P/FCF- EPS past 5Y- ROI13.60% 52W High-78.00% Beta-
Dividend %- Quick Ratio10.30 Sales past 5Y- Gross Margin- 52W Low9.03% ATR1.17
Employees206 Current Ratio10.30 Sales Q/Q4253.50% Oper. Margin- RSI (14)36.06 Volatility7.63% 6.59%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.58 Prev Close15.17
ShortableYes LT Debt/Eq0.00 EarningsAug 12 AMC Payout- Avg Volume1.73M Price15.82
Recom1.60 SMA20-7.52% SMA50-27.69% SMA200-51.35% Volume999,118 Change4.28%
Jan-05-21Initiated SVB Leerink Outperform $45
Jan-05-21Initiated Stifel Buy $59
Jan-05-21Initiated Credit Suisse Outperform $52
Jan-05-21Initiated BMO Capital Markets Outperform $48
Jan-05-21Initiated Berenberg Buy $53
Jul-22-21 04:05PM  
Jul-21-21 10:15AM  
Jul-14-21 05:22PM  
Jul-13-21 09:00AM  
Jun-30-21 11:32AM  
Jun-22-21 09:00AM  
Jun-10-21 05:11PM  
May-16-21 03:02AM  
May-14-21 08:48PM  
04:07PM  
May-13-21 11:30PM  
May-11-21 04:05PM  
May-06-21 09:00AM  
May-04-21 09:31AM  
06:30AM  
Apr-29-21 04:10PM  
Apr-21-21 04:05PM  
Apr-20-21 11:37AM  
Apr-15-21 07:49AM  
Apr-14-21 04:05PM  
Apr-12-21 04:05PM  
Apr-05-21 02:00PM  
Apr-01-21 09:00AM  
05:38AM  
Mar-29-21 04:05PM  
Mar-25-21 11:51AM  
Mar-16-21 12:51PM  
Mar-13-21 01:00AM  
Mar-10-21 11:21AM  
Mar-05-21 03:30PM  
Feb-27-21 09:23AM  
Feb-17-21 04:05PM  
Feb-11-21 04:05PM  
Feb-10-21 04:15PM  
Feb-09-21 08:26PM  
Feb-03-21 04:05PM  
Jan-28-21 01:08PM  
Jan-27-21 07:22AM  
Jan-26-21 07:09AM  
Jan-21-21 08:27AM  
Jan-19-21 04:41PM  
Dec-21-20 09:00AM  
Dec-15-20 09:03PM  
Dec-11-20 05:39PM  
05:25PM  
Dec-10-20 10:47PM  
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. As of December 31, 2020, the company had 103 discovery programs that are either completed, in progress, or under contract. It has a discovery partnership agreement with Eli Lilly and Company. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hayden Michael RDirectorJun 22Sale25.50100,0002,550,0001,003,397Jun 22 06:50 PM
Lecault VeroniqueChief Operating OfficerJun 15Option Exercise0.19333,33363,3331,339,333Jun 16 08:00 PM
Thermopylae Holdings Ltd.10% OwnerJun 09Sale24.035,598,420134,530,03355,604,330Jun 10 05:14 PM
Hansen Carl L. G.Chief Executive OfficerJun 09Sale24.136,000,000144,770,323233,500Jun 10 05:11 PM
Lecault VeroniqueChief Operating OfficerJun 09Sale25.501,000,00025,500,000273,630Jun 10 05:01 PM
Booth AndrewChief Financial OfficerJun 09Sale25.501,200,00030,600,0000Jun 10 05:00 PM
Falconer EsterChief Technology OfficerJun 09Sale25.501,000,00025,500,0000Jun 10 05:00 PM
Stimart TrynChief Legal OfficerJun 09Sale25.501,000,00025,500,000250Jun 10 05:01 PM
Booth AndrewChief Financial OfficerJun 07Option Exercise0.261,200,000306,0001,200,000Jun 09 08:30 PM
Stimart TrynChief Legal OfficerJun 07Option Exercise0.811,000,000815,0001,000,250Jun 09 08:30 PM
Falconer EsterChief Technology OfficerMar 19Option Exercise0.031,000,00034,3001,000,000Apr 23 08:00 PM
ABNB Airbnb, Inc. daily Stock Chart
ABNB [NASD]
Airbnb, Inc.
Index- P/E- EPS (ttm)-16.22 Insider Own7.20% Shs Outstand600.96M Perf Week2.46%
Market Cap89.51B Forward P/E- EPS next Y-0.09 Insider Trans-10.11% Shs Float192.26M Perf Month-4.96%
Income-5416.30M PEG- EPS next Q-0.48 Inst Own46.20% Short Float5.16% Perf Quarter-13.46%
Sales3.42B P/S26.15 EPS this Y87.40% Inst Trans2.73% Short Ratio1.14 Perf Half Y-19.37%
Book/sh5.26 P/B27.66 EPS next Y93.90% ROA- Target Price172.50 Perf Year-
Cash/sh10.68 P/C13.63 EPS next 5Y- ROE- 52W Range121.50 - 219.94 Perf YTD-0.89%
Dividend- P/FCF220.95 EPS past 5Y- ROI-74.20% 52W High-33.85% Beta-
Dividend %- Quick Ratio1.70 Sales past 5Y29.70% Gross Margin50.50% 52W Low19.74% ATR4.38
Employees5597 Current Ratio1.70 Sales Q/Q5.40% Oper. Margin- RSI (14)53.78 Volatility2.27% 3.14%
OptionableYes Debt/Eq0.63 EPS Q/Q-241.40% Profit Margin- Rel Volume0.52 Prev Close144.01
ShortableYes LT Debt/Eq0.63 EarningsAug 12 AMC Payout- Avg Volume8.70M Price145.49
Recom2.50 SMA202.63% SMA500.66% SMA200-11.79% Volume4,510,859 Change1.03%
Jul-22-21Upgrade BTIG Research Neutral → Buy $170
Jul-13-21Upgrade Gordon Haskett Underperform → Buy $172
May-27-21Initiated RBC Capital Mkts Outperform $170
May-14-21Upgrade Wells Fargo Equal Weight → Overweight $200
Apr-27-21Initiated Needham Buy $210
Apr-06-21Initiated Evercore ISI Outperform $245
Apr-01-21Initiated Wolfe Research Peer Perform $180
Mar-10-21Resumed Citigroup Neutral $197
Feb-26-21Reiterated Canaccord Genuity Buy $175 → $270
Feb-22-21Upgrade Loop Capital Hold → Buy $150 → $240
Feb-12-21Downgrade Wolfe Research Outperform → Peer Perform
Feb-09-21Initiated HSBC Securities Buy $220
Jan-15-21Initiated Truist Hold $154
Jan-11-21Initiated Tigress Financial Buy
Jan-05-21Initiated William Blair Outperform
Jan-05-21Initiated Citigroup Neutral $165
Jan-05-21Downgrade Atlantic Equities Overweight → Neutral $120
Jan-04-21Initiated Wells Fargo Equal Weight $160
Jan-04-21Initiated Wedbush Neutral
Jan-04-21Initiated Stifel Hold $130
Aug-01-21 11:59PM  
05:51AM  
Jul-30-21 08:33AM  
08:08AM  
Jul-29-21 04:05PM  
10:00AM  
Jul-28-21 05:45PM  
11:27AM  
07:05AM  
Jul-27-21 05:45PM  
08:44AM  
05:46AM  
02:00AM  
Jul-26-21 03:01PM  
Jul-25-21 07:18AM  
Jul-23-21 07:42PM  
04:03PM  
07:45AM  
07:39AM  
Jul-22-21 05:45PM  
03:01PM  
02:20PM  
02:10PM  
12:20PM  
Jul-21-21 09:22AM  
08:00AM  
Jul-20-21 11:30AM  
09:00AM  
07:40AM  
03:32AM  
Jul-19-21 04:42PM  
Jul-17-21 11:05AM  
Jul-16-21 04:54PM  
12:59PM  
09:30AM  
07:42AM  
Jul-15-21 05:45PM  
01:53PM  
07:45AM  
07:34AM  
Jul-14-21 10:49AM  
Jul-13-21 11:54AM  
10:18AM  
06:02AM  
Jul-11-21 08:15AM  
Jul-10-21 06:15PM  
Jul-09-21 12:34PM  
12:01PM  
10:58AM  
09:00AM  
Jul-08-21 08:00AM  
Jul-07-21 05:00PM  
08:45AM  
05:51AM  
Jul-06-21 04:26PM  
03:43PM  
01:37PM  
12:16PM  
11:18AM  
Jul-01-21 05:45PM  
Jun-30-21 11:26AM  
07:07AM  
Jun-29-21 12:00PM  
08:17AM  
07:00AM  
05:59AM  
Jun-28-21 11:00AM  
11:00AM  
10:45AM  
05:51AM  
02:25AM  
Jun-26-21 12:55PM  
Jun-24-21 05:45PM  
08:51AM  
08:15AM  
07:11AM  
Jun-23-21 03:05PM  
12:51PM  
12:00PM  
06:30AM  
Jun-22-21 10:46AM  
09:52AM  
Jun-21-21 04:05PM  
12:00PM  
11:30AM  
08:48AM  
06:21AM  
Jun-18-21 05:45PM  
08:00AM  
07:58AM  
05:01AM  
Jun-17-21 02:02PM  
05:30AM  
Jun-16-21 05:07PM  
01:00PM  
Jun-14-21 11:41AM  
06:11AM  
05:55AM  
Jun-13-21 07:32AM  
Jun-11-21 01:00PM  
Airbnb, Inc., together with its subsidiaries, operates a platform for stays and experiences to guests worldwide. The company's marketplace model connects hosts and guests online or through mobile devices to book spaces and experiences. It primarily offers private rooms and luxury villas. The company was formerly known as AirBed & Breakfast, Inc. and changed its name to Airbnb, Inc. in November 2010. Airbnb, Inc. was founded in 2007 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Johnson Belinda J.DirectorJul 28Sale141.1325,0003,528,250199,327Jul 30 04:30 PM
Blecharczyk NathanChief Strategy OfficerJul 21Sale140.00122,30917,123,260550,118Jul 23 04:30 PM
Blecharczyk NathanChief Strategy OfficerJul 15Sale140.0811,0631,549,706672,427Jul 16 08:09 PM
Blecharczyk NathanChief Strategy OfficerJul 14Sale140.91741,628104,501,323683,490Jul 16 08:09 PM
Johnson Belinda J.DirectorJul 14Sale143.8025,0003,595,000199,327Jul 16 08:15 PM
BALOGH ARISTOTLE NChief Technology OfficerJul 01Sale154.704,000618,806347,568Jul 06 09:01 PM
Gebbia JosephSee RemarksJul 01Sale154.2358,3338,996,6411,395,154Jul 06 08:58 PM
Gebbia JosephSee RemarksJul 01Sale154.16145,83322,482,037261,599Jul 06 08:58 PM
Johnson Belinda J.DirectorJun 30Sale145.7125,0003,642,750199,327Jul 02 07:00 PM
Johnson Belinda J.DirectorJun 16Sale150.9525,0003,773,750199,327Jun 21 06:37 PM
Blecharczyk NathanChief Strategy OfficerJun 14Sale148.33875,000129,787,963812,618Jun 16 08:08 PM
Johnson Belinda J.DirectorJun 09Sale147.14200,00029,427,043199,327Jun 11 06:11 PM
Bernstein David CChief Accounting OfficerJun 07Option Exercise2.1210,00021,15082,454Jun 09 07:57 PM
Bernstein David CChief Accounting OfficerJun 07Sale149.125,032750,34777,422Jun 09 07:57 PM
Johnson Belinda J.DirectorJun 02Sale144.8525,0003,621,250199,327Jun 04 08:53 PM
BALOGH ARISTOTLE NChief Technology OfficerJun 02Sale150.0010,0001,500,000351,568Jun 03 09:48 PM
BALOGH ARISTOTLE NChief Technology OfficerJun 01Sale143.824,000575,280361,568Jun 03 09:48 PM
Gebbia JosephSee RemarksJun 01Sale143.821,731,225248,992,327261,599Jun 03 09:52 PM
Blecharczyk NathanChief Strategy OfficerMay 27Sale140.00486,11168,055,540550,118Jun 01 09:44 PM
MATHER ANNDirectorMay 26Sale134.751,158156,0405,805May 27 09:31 PM
Stephenson DaveChief Financial OfficerMay 25Sale137.5015,2022,090,275331,754May 27 09:38 PM
Bernstein David CChief Accounting OfficerMay 24Option Exercise2.125,00010,57577,135May 26 06:48 PM
Bernstein David CChief Accounting OfficerMay 24Sale135.152,522340,84974,163May 26 06:48 PM
Stephenson DaveChief Financial OfficerMay 17Option Exercise40.1833,0001,325,940394,839May 19 09:00 PM
Johnson Belinda J.DirectorMay 17Sale137.001,000137,000197,254May 19 09:00 PM
POWELL CATHERINE CGlobal Head of HostingMay 17Sale136.0910013,609152,391May 19 09:00 PM
MATHER ANNDirectorMay 17Sale136.343,306450,7366,463May 19 09:00 PM
Stephenson DaveChief Financial OfficerMay 17Sale136.9647,8836,557,965346,956May 19 09:00 PM
BALOGH ARISTOTLE NChief Technology OfficerMay 17Sale137.00506,850380,120May 19 09:00 PM
Blecharczyk NathanChief Strategy OfficerMay 17Sale132.65388,98951,598,633297,325May 19 09:00 PM
Gebbia JosephSee RemarksMay 17Sale136.071,028139,880296,417May 19 09:00 PM
ACA Arcosa, Inc. daily Stock Chart
ACA [NYSE]
Arcosa, Inc.
Index- P/E28.82 EPS (ttm)1.86 Insider Own1.60% Shs Outstand48.00M Perf Week1.73%
Market Cap2.60B Forward P/E21.27 EPS next Y2.52 Insider Trans-5.00% Shs Float47.72M Perf Month-8.51%
Income90.30M PEG7.03 EPS next Q0.57 Inst Own92.05% Short Float1.27% Perf Quarter-15.65%
Sales1.89B P/S1.38 EPS this Y-5.90% Inst Trans9.46% Short Ratio2.97 Perf Half Y-7.61%
Book/sh39.82 P/B1.35 EPS next Y27.12% ROA3.40% Target Price69.25 Perf Year27.05%
Cash/sh1.69 P/C31.75 EPS next 5Y4.10% ROE4.80% 52W Range40.44 - 68.46 Perf YTD-2.35%
Dividend0.20 P/FCF20.28 EPS past 5Y-4.70% ROI5.60% 52W High-21.65% Beta-
Dividend %0.37% Quick Ratio1.30 Sales past 5Y-2.00% Gross Margin19.30% 52W Low32.64% ATR1.69
Employees6410 Current Ratio2.20 Sales Q/Q-9.80% Oper. Margin6.90% RSI (14)42.33 Volatility3.39% 3.02%
OptionableYes Debt/Eq0.13 EPS Q/Q-49.60% Profit Margin4.80% Rel Volume0.71 Prev Close54.76
ShortableYes LT Debt/Eq0.13 EarningsAug 04 AMC Payout10.60% Avg Volume203.12K Price53.64
Recom2.20 SMA20-1.35% SMA50-7.39% SMA200-7.82% Volume144,297 Change-2.05%
Jul-26-21Upgrade Sidoti Neutral → Buy $66
May-03-21Upgrade Gabelli & Co Hold → Buy
Feb-22-21Downgrade Sidoti Buy → Neutral $64 → $67
Dec-15-20Downgrade CJS Securities Market Outperform → Market Perform
Nov-19-20Downgrade Gabelli & Co Buy → Hold
Sep-18-19Initiated Sidoti Buy $47
Jul-28-21 03:03PM  
Jul-27-21 05:36PM  
Jul-15-21 01:18AM  
Jul-14-21 04:15PM  
May-31-21 01:27AM  
May-27-21 04:15PM  
May-07-21 01:00AM  
May-06-21 02:30AM  
May-04-21 04:15PM  
08:00AM  
Apr-30-21 12:00PM  
Apr-29-21 06:15PM  
04:15PM  
Apr-22-21 12:33PM  
Apr-19-21 08:00AM  
Apr-16-21 01:26AM  
Apr-12-21 08:00AM  
Apr-09-21 04:15PM  
Mar-31-21 06:19PM  
Mar-29-21 03:47PM  
10:11AM  
07:42AM  
Mar-23-21 07:30PM  
08:24AM  
Mar-22-21 04:15PM  
Mar-04-21 04:15PM  
Mar-01-21 11:35PM  
Feb-26-21 05:00PM  
03:52AM  
Feb-25-21 06:30AM  
Feb-24-21 04:40PM  
04:15PM  
Feb-01-21 04:15PM  
Jan-24-21 11:21PM  
Jan-13-21 10:18AM  
Dec-24-20 10:30AM  
Dec-10-20 11:25PM  
Dec-03-20 04:15PM  
Nov-02-20 11:40AM  
10:50AM  
Oct-30-20 12:00PM  
12:02AM  
Oct-29-20 06:30AM  
Oct-28-20 06:15PM  
04:15PM  
09:22AM  
Oct-23-20 06:21AM  
Oct-21-20 12:32PM  
08:46AM  
Oct-13-20 11:13AM  
09:15AM  
Oct-12-20 08:00AM  
Oct-06-20 04:15PM  
09:59AM  
Sep-28-20 11:40AM  
Sep-22-20 05:46PM  
Sep-20-20 05:45PM  
Sep-12-20 09:15AM  
Sep-10-20 11:40AM  
Sep-06-20 07:27AM  
Sep-03-20 04:15PM  
Sep-01-20 04:15PM  
Aug-12-20 09:42AM  
Aug-05-20 04:15PM  
11:50AM  
Jul-31-20 11:02PM  
Jul-30-20 08:50PM  
04:15PM  
01:50PM  
Jul-29-20 06:23AM  
Jul-23-20 12:32PM  
Jul-09-20 04:15PM  
Jun-23-20 11:08PM  
May-15-20 12:38PM  
May-05-20 04:15PM  
Apr-29-20 01:30PM  
Apr-28-20 06:55PM  
04:15PM  
Apr-18-20 08:01AM  
Apr-17-20 04:26PM  
06:16AM  
Apr-13-20 04:15PM  
Apr-08-20 07:11PM  
12:00PM  
11:40AM  
Mar-21-20 08:01AM  
Mar-05-20 04:15PM  
Feb-28-20 09:27AM  
Feb-27-20 11:50AM  
Feb-26-20 04:15PM  
12:43PM  
12:00PM  
Feb-24-20 09:07AM  
Feb-21-20 03:53PM  
Feb-20-20 05:45PM  
Feb-14-20 01:30AM  
Feb-06-20 11:30AM  
08:55AM  
Feb-04-20 11:40AM  
Feb-03-20 05:45PM  
Arcosa, Inc., together with its subsidiaries, provides infrastructure-related products and solutions for the construction, energy, and transportation markets in North America. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment offers natural and lightweight aggregates; specialty materials, including lightweight aggregates and plaster; trench shields and shoring products for residential and non-residential construction, agriculture, specialty building products, and underground construction markets, as well as for infrastructure, including road, bridge, and other public products markets. The Engineered Structures segment provides utility structures, wind towers, traffic and lighting structures, telecommunication structures, storage and distribution tanks for electricity transmission and distribution, wind power generation, highway road construction, and wireless communication markets, as well as for gas and liquids storage and transportation for residential, commercial, agriculture, and industrial markets. The Transportation Products segment offers inland barges; fiberglass barge covers, winches, and other components; axles and couplers for railcars and locomotives; industrial and military castings, and forged products for transportation products serving various markets, including agriculture/food, refined, chemicals, upstream oil, and railcar manufacturers and maintenance operations industries. Arcosa, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Henderson Mary ECAOJun 02Sale60.9910,000609,90039,667Jun 03 09:41 AM
Cole Kerry SGroup PresidentJun 01Sale63.3616,0251,015,34427,091Jun 02 02:37 PM
Collins Jesse E. Jr.Group PresidentMay 28Sale62.4910,990686,76518,097Jun 01 03:41 PM
GAFFORD RONALD JDirectorMay 21Sale62.143,788235,38625,106May 24 12:09 PM
ACC American Campus Communities, Inc. daily Stock Chart
ACC [NYSE]
American Campus Communities, Inc.
Index- P/E98.72 EPS (ttm)0.51 Insider Own0.90% Shs Outstand137.71M Perf Week-0.08%
Market Cap6.89B Forward P/E102.35 EPS next Y0.49 Insider Trans-2.37% Shs Float136.77M Perf Month6.16%
Income70.70M PEG5.60 EPS next Q-0.16 Inst Own97.50% Short Float1.83% Perf Quarter10.63%
Sales870.60M P/S7.91 EPS this Y-15.20% Inst Trans-0.39% Short Ratio2.81 Perf Half Y19.21%
Book/sh22.27 P/B2.25 EPS next Y444.44% ROA0.90% Target Price51.33 Perf Year40.71%
Cash/sh0.30 P/C167.62 EPS next 5Y17.62% ROE2.20% 52W Range31.07 - 51.69 Perf YTD17.26%
Dividend1.88 P/FCF78.11 EPS past 5Y-12.80% ROI2.70% 52W High-2.98% Beta0.95
Dividend %3.75% Quick Ratio- Sales past 5Y2.90% Gross Margin50.90% 52W Low61.41% ATR0.98
Employees2988 Current Ratio- Sales Q/Q-6.70% Oper. Margin21.00% RSI (14)55.36 Volatility2.09% 1.98%
OptionableYes Debt/Eq1.20 EPS Q/Q-81.50% Profit Margin8.10% Rel Volume0.67 Prev Close50.31
ShortableYes LT Debt/Eq1.20 EarningsJul 26 AMC Payout365.70% Avg Volume891.25K Price50.15
Recom2.10 SMA200.95% SMA503.27% SMA20014.37% Volume596,427 Change-0.32%
May-28-21Upgrade Piper Sandler Neutral → Overweight $48 → $55
May-20-21Upgrade JP Morgan Underweight → Neutral $46
May-10-21Upgrade Evercore ISI In-line → Outperform $48 → $50
Dec-21-20Downgrade JP Morgan Neutral → Underweight $40
Dec-15-20Upgrade Deutsche Bank Hold → Buy $49
Dec-14-20Downgrade Evercore ISI Outperform → In-line
Oct-05-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Sep-21-20Downgrade Piper Sandler Overweight → Neutral $38
Apr-02-20Upgrade Goldman Neutral → Buy $52 → $38
Mar-25-20Upgrade Evercore ISI In-line → Outperform $49 → $37
Nov-08-19Initiated Goldman Neutral $53
Jul-31-19Upgrade Argus Hold → Buy $53
Jul-08-19Upgrade CapitalOne Equal Weight → Overweight
May-29-19Downgrade JMP Securities Mkt Outperform → Mkt Perform
Dec-19-18Upgrade JP Morgan Underweight → Neutral
Jul-18-18Downgrade Argus Buy → Hold
Jun-14-18Upgrade BofA/Merrill Neutral → Buy
Feb-22-18Upgrade Hilliard Lyons Neutral → Long-term Buy
Jan-12-18Upgrade Sandler O'Neill Hold → Buy
Dec-20-17Reiterated KeyBanc Capital Mkts Overweight $56 → $47
Aug-01-21 03:05AM  
Jul-27-21 04:30PM  
Jul-26-21 05:45PM  
04:15PM  
Jul-20-21 06:54PM  
Jul-13-21 05:30PM  
03:05PM  
Jul-01-21 07:03AM  
Jun-22-21 06:04PM  
Jun-15-21 07:22AM  
Jun-07-21 06:20PM  
May-13-21 07:13PM  
May-11-21 09:45AM  
May-05-21 06:43PM  
Apr-28-21 04:59PM  
07:31AM  
Apr-20-21 03:00PM  
Apr-19-21 05:35PM  
04:15PM  
12:00PM  
Mar-23-21 08:55AM  
07:00AM  
Mar-17-21 09:27AM  
05:00AM  
Mar-02-21 11:34AM  
Feb-23-21 01:30PM  
07:45AM  
Feb-22-21 04:15PM  
Feb-17-21 07:45AM  
Feb-15-21 07:13PM  
Feb-02-21 06:37PM  
Feb-01-21 11:16PM  
Jan-27-21 05:16PM  
Jan-26-21 04:58PM  
10:43AM  
Jan-18-21 05:47PM  
Dec-18-20 10:20PM  
Dec-16-20 02:00PM  
Dec-12-20 04:00PM  
Dec-04-20 10:54AM  
Nov-22-20 09:00AM  
Nov-04-20 06:59PM  
12:00PM  
05:35AM  
Oct-27-20 09:01PM  
Oct-26-20 05:45PM  
04:15PM  
Oct-20-20 02:42PM  
Oct-08-20 12:32PM  
Sep-28-20 05:24PM  
Sep-24-20 05:00PM  
Sep-14-20 02:23PM  
08:30AM  
Sep-10-20 04:32PM  
Sep-05-20 10:45AM  
Aug-19-20 11:30AM  
Aug-12-20 02:33AM  
Jul-29-20 06:24PM  
Jul-22-20 12:33PM  
Jul-21-20 06:30PM  
10:13AM  
Jul-20-20 06:05PM  
04:46PM  
01:47PM  
08:49AM  
Jul-07-20 06:42AM  
Jul-01-20 01:11AM  
Jun-15-20 06:30PM  
Jun-10-20 08:50PM  
Jun-09-20 06:30PM  
Jun-01-20 08:48PM  
May-29-20 02:31PM  
May-25-20 07:50AM  
May-01-20 01:37PM  
Apr-29-20 05:25PM  
Apr-22-20 12:31PM  
Apr-21-20 12:32PM  
08:00AM  
Apr-20-20 04:15PM  
Apr-17-20 11:43AM  
Apr-08-20 04:15PM  
Mar-30-20 04:59PM  
Mar-26-20 05:24PM  
Mar-23-20 04:15PM  
Mar-20-20 02:13PM  
Mar-12-20 04:10PM  
Mar-05-20 02:23PM  
Feb-25-20 02:06AM  
Feb-18-20 04:14PM  
Jan-20-20 10:00AM  
Jan-15-20 07:08PM  
Jan-08-20 04:15PM  
Jan-07-20 05:09AM  
Jan-03-20 07:00AM  
Dec-27-19 09:19AM  
Dec-09-19 12:23PM  
Dec-05-19 04:03PM  
Nov-21-19 01:22PM  
Nov-20-19 09:11AM  
Nov-12-19 05:00AM  
American Campus Communities, Inc. is the largest owner, manager and developer of high-quality student housing communities in the United States. The company is a fully integrated, self-managed and self-administered equity real estate investment trust (REIT) with expertise in the design, finance, development, construction management and operational management of student housing properties. As of September 30, 2020, American Campus Communities owned 166 student housing properties containing approximately 111,900 beds. Including its owned and third-party managed properties, ACC's total managed portfolio consisted of 204 properties with approximately 139,900 beds.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wilhelm James E IIIEVP PublicPrivate TransactionsJul 20Sale51.004,742241,84246,892Jul 22 03:02 PM
Beese JenniferEVP, Chief Operating OfficerJun 02Sale48.5810,000485,800105,448Jun 04 01:20 PM
Oles PatrickDirectorApr 28Option Exercise0.001,612014,087Apr 30 11:39 AM
BULLS HERMAN EDirectorApr 28Option Exercise0.002,72405,742Apr 30 11:39 AM
Donnell CydneyDirectorApr 28Option Exercise0.003,780028,851Apr 30 11:38 AM
Rippel John TDirectorApr 28Option Exercise0.002,724014,773Apr 30 11:39 AM
Egan MaryDirectorApr 28Option Exercise0.002,724011,558Apr 30 11:39 AM
Leupold CraigDirectorApr 28Option Exercise0.002,72405,742Apr 30 11:37 AM
Hill AlisonDirectorApr 28Option Exercise0.002,72405,742Apr 30 11:37 AM
DAWSON G STEVENDirectorApr 28Option Exercise0.002,724022,101Apr 30 11:38 AM
Hopke James Clarence JrPresidentApr 22Sale45.5015,243693,556118,149Apr 26 06:14 PM
Hill AlisonDirectorJan 27Option Exercise0.003,01803,018Feb 08 07:59 PM
Leupold CraigDirectorJan 27Option Exercise0.003,01803,018Feb 08 07:57 PM
BULLS HERMAN EDirectorJan 27Option Exercise0.003,01803,018Feb 08 07:57 PM
Bayless William C JrChief Executive OfficerSep 22Sale35.12120,0004,214,400305,891Sep 24 07:00 PM
ACGL Arch Capital Group Ltd. daily Stock Chart
ACGL [NASD]
Arch Capital Group Ltd.
Index- P/E7.88 EPS (ttm)4.98 Insider Own1.50% Shs Outstand400.81M Perf Week1.29%
Market Cap15.62B Forward P/E9.77 EPS next Y4.01 Insider Trans-2.00% Shs Float399.16M Perf Month-1.85%
Income2.03B PEG0.14 EPS next Q0.73 Inst Own99.30% Short Float1.25% Perf Quarter-2.32%
Sales9.13B P/S1.71 EPS this Y-14.20% Inst Trans-0.21% Short Ratio2.83 Perf Half Y22.45%
Book/sh30.73 P/B1.28 EPS next Y25.37% ROA3.20% Target Price48.88 Perf Year27.51%
Cash/sh2.36 P/C16.58 EPS next 5Y55.48% ROE11.50% 52W Range27.41 - 41.28 Perf YTD8.71%
Dividend- P/FCF5.49 EPS past 5Y19.50% ROI10.10% 52W High-5.01% Beta0.85
Dividend %- Quick Ratio- Sales past 5Y16.30% Gross Margin- 52W Low43.05% ATR0.82
Employees4500 Current Ratio- Sales Q/Q42.70% Oper. Margin18.20% RSI (14)55.64 Volatility2.22% 2.03%
OptionableYes Debt/Eq0.24 EPS Q/Q223.70% Profit Margin14.90% Rel Volume1.80 Prev Close39.00
ShortableYes LT Debt/Eq0.24 EarningsJul 28 AMC Payout0.00% Avg Volume1.76M Price39.21
Recom1.90 SMA202.40% SMA500.98% SMA2007.49% Volume3,157,282 Change0.54%
Jan-19-21Upgrade JMP Securities Mkt Perform → Mkt Outperform $43
May-22-20Resumed BofA/Merrill Buy $39
Jan-06-20Upgrade Wells Fargo Equal Weight → Overweight $48
Nov-12-19Downgrade JP Morgan Overweight → Neutral $44 → $40
Jul-19-19Downgrade Buckingham Research Buy → Neutral $38
Jun-27-19Upgrade Deutsche Bank Hold → Buy
Jan-09-19Upgrade Barclays Equal Weight → Overweight $29 → $32
Aug-07-18Initiated Credit Suisse Neutral
Jun-18-18Initiated Goldman Neutral $88
Mar-22-18Upgrade Keefe Bruyette Mkt Perform → Outperform
Sep-11-17Initiated Buckingham Research Buy $106
Jan-06-17Initiated Credit Suisse Outperform
Sep-07-16Upgrade Goldman Sell → Neutral
Sep-06-16Upgrade UBS Neutral → Buy $73 → $98
Aug-17-16Reiterated RBC Capital Mkts Outperform $80 → $87
Feb-11-16Reiterated RBC Capital Mkts Outperform $85 → $79
Jan-19-16Downgrade Macquarie Outperform → Neutral
Nov-11-15Initiated Nomura Neutral
Oct-30-15Reiterated RBC Capital Mkts Outperform $77 → $85
Oct-30-15Downgrade BofA/Merrill Neutral → Underperform
Jul-30-21 01:02AM  
Jul-29-21 08:36AM  
Jul-28-21 04:11PM  
Jul-27-21 10:21AM  
09:26AM  
09:10AM  
Jul-26-21 12:10PM  
Jul-23-21 10:49AM  
10:36AM  
10:27AM  
Jul-22-21 10:52AM  
Jul-17-21 03:07AM  
Jul-02-21 08:30AM  
Jun-29-21 09:31AM  
08:13AM  
Jun-23-21 11:09AM  
Jun-14-21 09:35AM  
Jun-02-21 04:28PM  
May-27-21 11:31AM  
May-24-21 09:00AM  
May-13-21 01:02PM  
Apr-28-21 06:31PM  
10:21AM  
Apr-27-21 05:02PM  
Apr-26-21 06:45PM  
Apr-20-21 09:51AM  
Apr-19-21 09:24AM  
Apr-16-21 08:45AM  
Apr-08-21 01:00PM  
Mar-24-21 12:00PM  
Mar-18-21 01:26PM  
09:05AM  
Mar-17-21 08:50PM  
Mar-11-21 11:30AM  
Mar-05-21 11:15AM  
Mar-02-21 10:05AM  
Mar-01-21 10:34AM  
Feb-11-21 12:30AM  
Feb-10-21 10:41AM  
Feb-09-21 04:22PM  
Feb-08-21 08:44AM  
Feb-05-21 10:56AM  
Jan-22-21 09:54AM  
Jan-21-21 04:15PM  
Jan-15-21 10:11AM  
Jan-08-21 09:10AM  
09:00AM  
Dec-29-20 09:00AM  
Dec-22-20 12:52PM  
Dec-15-20 10:21AM  
Dec-14-20 09:33AM  
Dec-10-20 04:55PM  
04:40PM  
Dec-04-20 05:22PM  
08:01AM  
Dec-02-20 10:41AM  
Nov-30-20 09:54AM  
Nov-29-20 01:02AM  
Nov-25-20 09:36AM  
Nov-20-20 09:52AM  
Nov-19-20 03:26PM  
Nov-16-20 09:59AM  
Nov-10-20 11:40AM  
10:48AM  
Nov-03-20 02:47PM  
10:13AM  
Nov-02-20 09:47AM  
09:20AM  
Oct-30-20 06:00PM  
12:08PM  
Oct-29-20 04:11PM  
Oct-28-20 10:05AM  
06:00AM  
Oct-26-20 08:37PM  
Oct-17-20 07:11AM  
Oct-16-20 06:44PM  
Oct-15-20 10:04AM  
06:02AM  
Oct-14-20 09:59AM  
Oct-13-20 04:20PM  
Oct-12-20 06:50PM  
06:20PM  
10:15AM  
08:00AM  
Oct-09-20 12:43PM  
08:30AM  
Oct-08-20 02:40PM  
Sep-11-20 02:17PM  
09:43AM  
Sep-08-20 11:11PM  
Aug-28-20 11:31AM  
Jul-31-20 02:00PM  
Jul-30-20 11:50AM  
Jul-29-20 04:23PM  
04:11PM  
Jul-15-20 09:56AM  
Jul-14-20 04:05PM  
Jul-13-20 12:52PM  
Jul-10-20 04:19PM  
Jul-08-20 12:08PM  
Arch Capital Group Ltd., together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products worldwide. The company's Insurance segment offers primary and excess casualty coverages; loss sensitive primary casualty insurance programs; collateral protection, debt cancellation, and service contract reimbursement products; directors' and officers' liability, errors and omissions liability, employment practices and fiduciary liability, crime, professional indemnity, and other financial related coverages; medical professional and general liability insurance coverages; and workers' compensation and umbrella liability, as well as commercial automobile, and inland marine products. It also provides property, energy, marine, and aviation insurance; travel insurance; accident, disability, and medical plan insurance coverages; captive insurance programs; employer's liability; and contract and commercial surety coverages. This segment markets its products through a group of licensed independent retail and wholesale brokers. Its Reinsurance segment provides reinsurance for third party liability and workers' compensation exposures; marine and aviation reinsurance; surety, accident and health, workers' compensation catastrophe, agriculture, trade credit, and political risk products; reinsurance protection for catastrophic losses, and personal lines and commercial property exposures; life reinsurance; casualty clash; and risk management solutions. This segment markets its reinsurance products through brokers. The company's Mortgage segment offers direct mortgage insurance and mortgage reinsurance. The company was founded in 1995 and is based in Pembroke, Bermuda.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Posner Brian SDirectorJun 14Sale25.244,000100,9712,000Jun 15 06:14 PM
Hutchings W PrestonSVP & Chief Investment OfficerMay 27Sale39.5137,5001,481,715427,097Jun 01 03:27 PM
PETRILLO LOUIS TOfficer of SubsidiaryMay 20Sale40.2130,3601,220,642106,316May 20 06:47 PM
PETRILLO LOUIS TOfficer of SubsidiaryMay 18Option Exercise12.8636,000462,960160,187May 20 06:47 PM
Rajeh MaamounChairman & CEO Arch Re GroupMay 17Sale40.455,496222,314365,514May 20 06:33 PM
Morin FrancoisEVP and CFOMay 14Sale40.1515,000602,292181,304May 18 05:42 PM
Rajeh MaamounChairman & CEO Arch Re GroupMay 10Sale40.5229,7901,207,025371,010May 12 04:41 PM
GRANDISSON MARCCEOMay 06Option Exercise11.3036,000406,9552,139,520May 07 04:20 PM
GRANDISSON MARCCEOMay 05Option Exercise11.3036,000406,9552,113,646May 07 04:20 PM
Rajeh MaamounChairman & CEO Arch Re GroupMay 05Option Exercise13.2357,213756,928419,634May 07 04:11 PM
Gansberg DavidCEO, Global Mortgage GroupMar 12Option Exercise11.309,900111,913147,635Mar 16 04:24 PM
Hutchings W PrestonSVP & Chief Investment OfficerMar 12Option Exercise11.3050,400569,737438,384Mar 16 04:10 PM
ACHC Acadia Healthcare Company, Inc. daily Stock Chart
ACHC [NASD]
Acadia Healthcare Company, Inc.
Index- P/E37.74 EPS (ttm)1.64 Insider Own0.70% Shs Outstand89.74M Perf Week0.34%
Market Cap5.54B Forward P/E22.03 EPS next Y2.80 Insider Trans-26.43% Shs Float88.35M Perf Month-2.83%
Income144.20M PEG4.48 EPS next Q0.63 Inst Own- Short Float3.21% Perf Quarter-0.56%
Sales2.13B P/S2.60 EPS this Y169.00% Inst Trans0.10% Short Ratio7.62 Perf Half Y16.51%
Book/sh26.04 P/B2.37 EPS next Y14.13% ROA- Target Price68.09 Perf Year107.11%
Cash/sh2.00 P/C30.95 EPS next 5Y8.43% ROE- 52W Range27.07 - 68.00 Perf YTD22.84%
Dividend- P/FCF- EPS past 5Y-0.60% ROI5.30% 52W High-9.21% Beta1.56
Dividend %- Quick Ratio1.30 Sales past 5Y3.10% Gross Margin- 52W Low128.08% ATR1.72
Employees28600 Current Ratio1.30 Sales Q/Q8.20% Oper. Margin- RSI (14)48.23 Volatility2.60% 2.80%
OptionableYes Debt/Eq0.66 EPS Q/Q19.00% Profit Margin- Rel Volume1.18 Prev Close61.72
ShortableYes LT Debt/Eq0.65 EarningsAug 02 AMC Payout- Avg Volume372.00K Price61.74
Recom2.10 SMA200.20% SMA50-2.41% SMA20014.20% Volume439,001 Change0.03%
Jul-09-21Initiated Seaport Global Securities Neutral
Nov-17-20Upgrade UBS Neutral → Buy $37 → $54
Sep-30-20Upgrade Raymond James Outperform → Strong Buy $40 → $48
Jan-28-20Initiated Stephens Equal-Weight $36
Dec-11-19Downgrade Wells Fargo Outperform → Market Perform
Jul-31-19Downgrade Raymond James Strong Buy → Outperform $45
Jan-03-19Initiated Deutsche Bank Hold $27
Nov-16-18Initiated UBS Neutral $39
Jan-30-18Resumed Wells Fargo Outperform
Nov-03-17Initiated Credit Suisse Neutral
Oct-25-17Downgrade Robert W. Baird Outperform → Neutral $55 → $38
Oct-25-17Downgrade Deutsche Bank Buy → Hold $60 → $37
Jul-28-17Reiterated Mizuho Buy $57 → $60
Jul-18-17Initiated William Blair Outperform
May-15-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-05-17Initiated Deutsche Bank Buy $53
Feb-27-17Reiterated Mizuho Buy $45 → $52
Jan-27-17Downgrade Cantor Fitzgerald Overweight → Neutral
Jan-11-17Reiterated KeyBanc Capital Mkts Overweight $58 → $52
Jan-04-17Initiated Citigroup Buy
Aug-02-21 04:05PM  
Jul-26-21 03:00PM  
Jul-12-21 11:00AM  
Jul-06-21 10:21AM  
Jul-01-21 09:28AM  
Jun-30-21 11:00AM  
11:00AM  
Jun-23-21 01:11PM  
06:54AM  
Jun-22-21 12:27PM  
Jun-17-21 01:17AM  
Jun-11-21 08:00AM  
Jun-10-21 09:17AM  
Jun-01-21 10:41AM  
May-26-21 12:15PM  
May-18-21 12:30PM  
May-12-21 01:25AM  
May-05-21 11:00AM  
May-04-21 07:10AM  
Apr-30-21 01:35PM  
12:30PM  
Apr-29-21 04:05PM  
Apr-22-21 12:33PM  
Apr-14-21 12:24PM  
Apr-09-21 09:00AM  
Apr-06-21 07:15AM  
01:26AM  
Mar-31-21 01:22PM  
Mar-30-21 10:00AM  
Mar-29-21 10:00AM  
Mar-27-21 11:31AM  
Mar-25-21 11:30AM  
Mar-23-21 10:00AM  
Mar-22-21 01:03PM  
Mar-19-21 10:15AM  
Mar-09-21 11:24AM  
Feb-28-21 11:13PM  
Feb-26-21 03:32PM  
11:03AM  
Feb-25-21 04:41PM  
11:00AM  
Feb-24-21 10:14AM  
Feb-18-21 06:45PM  
Feb-10-21 11:00AM  
Feb-09-21 01:00PM  
08:30AM  
Jan-29-21 01:20PM  
Jan-22-21 12:00PM  
Jan-21-21 04:19PM  
01:56PM  
Jan-19-21 08:42AM  
Jan-11-21 09:51AM  
Jan-08-21 12:55PM  
Jan-05-21 10:15AM  
Dec-31-20 11:15AM  
10:05AM  
Dec-30-20 02:50PM  
10:01AM  
08:08AM  
08:00AM  
Dec-29-20 11:21PM  
08:48AM  
Dec-28-20 12:07PM  
Dec-21-20 12:00PM  
Dec-10-20 10:47AM  
Dec-09-20 12:00PM  
11:56AM  
09:56AM  
09:53AM  
09:00AM  
08:46AM  
Dec-01-20 12:00PM  
Nov-27-20 09:50AM  
Nov-20-20 11:42AM  
Nov-17-20 12:30PM  
Nov-16-20 10:27AM  
10:20AM  
Nov-12-20 12:51PM  
Nov-10-20 01:00AM  
Nov-05-20 11:00AM  
Nov-03-20 12:00PM  
Nov-02-20 10:34AM  
09:15AM  
08:02AM  
Oct-30-20 07:30PM  
04:16PM  
01:48PM  
10:36AM  
07:15AM  
Oct-29-20 06:45PM  
04:38PM  
04:05PM  
Oct-28-20 04:05PM  
10:09AM  
Oct-22-20 12:33PM  
Oct-20-20 12:00PM  
Oct-16-20 01:00PM  
Oct-09-20 12:39PM  
Oct-08-20 06:50PM  
Oct-07-20 02:34PM  
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or others by hourly observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorders. In addition, the company provides education and children's, and adult care services. As of March 31, 2021, it operated a network of 228 behavioral healthcare facilities with approximately 10,000 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hollinsworth John S.EVP of OperationsJun 14Sale66.315,000331,55056,275Jun 16 05:05 PM
WAUD REEVE BDirectorJun 14Sale66.4755,0303,657,844506,844Jun 16 05:05 PM
GRIECO WILLIAMDirectorMar 15Sale60.652,000121,30073,958Mar 16 05:10 PM
GRIECO WILLIAMDirectorMar 12Sale59.022,000118,04075,958Mar 16 05:10 PM
WAUD REEVE BDirectorMar 12Sale59.12109,4436,470,358561,874Mar 15 06:27 PM
Howard Christopher LEVP, GC and SecretaryMar 11Option Exercise23.9515,966382,402110,974Mar 15 05:01 PM
Duckworth David M.Chief Financial OfficerMar 11Option Exercise22.7118,780426,43290,553Mar 15 05:06 PM
Duckworth David M.Chief Financial OfficerMar 11Sale58.0418,7801,089,99171,773Mar 15 05:06 PM
Howard Christopher LEVP, GC and SecretaryMar 11Sale58.0933,2281,930,21595,008Mar 15 05:01 PM
GRIECO WILLIAMDirectorDec 14Option Exercise6.605,00033,00077,958Dec 16 05:02 PM
ACRS Aclaris Therapeutics, Inc. daily Stock Chart
ACRS [NASD]
Aclaris Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.41 Insider Own3.00% Shs Outstand50.34M Perf Week-0.26%
Market Cap936.17M Forward P/E- EPS next Y-1.25 Insider Trans-15.70% Shs Float48.55M Perf Month-12.38%
Income-64.60M PEG- EPS next Q-0.28 Inst Own80.50% Short Float7.23% Perf Quarter-39.49%
Sales6.90M P/S135.68 EPS this Y56.20% Inst Trans1.96% Short Ratio4.65 Perf Half Y-29.37%
Book/sh2.23 P/B6.76 EPS next Y1.50% ROA-66.00% Target Price- Perf Year601.40%
Cash/sh2.07 P/C7.30 EPS next 5Y- ROE-106.90% 52W Range1.82 - 30.38 Perf YTD133.08%
Dividend- P/FCF- EPS past 5Y-0.90% ROI-105.00% 52W High-50.35% Beta0.59
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin26.10% 52W Low728.57% ATR0.91
Employees60 Current Ratio9.30 Sales Q/Q28.60% Oper. Margin- RSI (14)39.47 Volatility5.74% 6.04%
OptionableYes Debt/Eq0.00 EPS Q/Q-55.10% Profit Margin- Rel Volume0.55 Prev Close14.93
ShortableYes LT Debt/Eq0.10 Earnings- Payout- Avg Volume754.98K Price15.08
Recom1.50 SMA20-5.27% SMA50-16.82% SMA200-5.64% Volume415,550 Change1.00%
Jul-23-21Resumed Jefferies Buy $27 → $32
Jun-15-21Initiated Piper Sandler Overweight $30
Apr-21-21Initiated H.C. Wainwright Buy $40
Oct-22-19Upgrade SVB Leerink Mkt Perform → Outperform
Sep-06-19Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-27-19Downgrade SVB Leerink Outperform → Mkt Perform
May-06-19Initiated SVB Leerink Outperform $13
Mar-28-18Resumed Leerink Partners Outperform $52
Feb-09-18Initiated Guggenheim Buy $53
Jun-16-17Initiated Cantor Fitzgerald Overweight $50
Nov-29-16Initiated Leerink Partners Outperform $54
Sep-30-16Initiated JMP Securities Mkt Outperform
Jun-10-16Initiated Guggenheim Buy $35
Nov-02-15Initiated Jefferies Buy $20
Nov-02-15Initiated Citigroup Buy
Jul-30-21 03:00PM  
Jul-08-21 07:00AM  
Jul-06-21 11:49AM  
10:13AM  
Jun-09-21 07:55PM  
11:00AM  
Jun-08-21 04:15PM  
03:16PM  
07:46AM  
07:00AM  
May-18-21 01:25AM  
May-17-21 07:00AM  
May-07-21 08:35AM  
07:00AM  
Apr-29-21 05:02PM  
Apr-26-21 01:39AM  
Mar-15-21 07:00AM  
Feb-25-21 07:00AM  
Feb-22-21 07:00AM  
Feb-10-21 07:00AM  
Jan-25-21 02:40PM  
Jan-20-21 01:25PM  
12:13PM  
10:30AM  
08:45AM  
07:32AM  
04:19AM  
Jan-19-21 04:34PM  
04:01PM  
12:10PM  
07:00AM  
Dec-28-20 11:17PM  
Dec-23-20 09:11AM  
Dec-15-20 11:26PM  
07:00AM  
Nov-16-20 04:01PM  
Nov-14-20 07:08AM  
Nov-06-20 12:00PM  
Nov-04-20 08:25AM  
07:00AM  
Oct-29-20 12:35PM  
Oct-21-20 10:46AM  
Oct-20-20 07:00AM  
Oct-14-20 10:36PM  
Oct-01-20 12:00PM  
Sep-30-20 06:40AM  
Sep-01-20 04:01PM  
Aug-13-20 12:00PM  
Aug-07-20 08:45AM  
07:00AM  
Aug-06-20 12:30PM  
Jul-08-20 08:43AM  
Jul-07-20 04:01PM  
Jun-26-20 02:30PM  
Jun-18-20 10:12AM  
Jun-17-20 10:37AM  
07:01AM  
Jun-03-20 07:00AM  
May-26-20 04:01PM  
May-12-20 10:47AM  
May-08-20 12:00PM  
May-07-20 04:01PM  
May-06-20 12:30PM  
Apr-09-20 06:13AM  
Apr-06-20 12:00PM  
Apr-01-20 11:07AM  
Mar-31-20 04:01PM  
Mar-17-20 02:46AM  
Feb-25-20 04:01PM  
Feb-24-20 07:31AM  
Feb-19-20 05:00PM  
Feb-10-20 07:00AM  
Jan-13-20 05:03PM  
Jan-10-20 07:13AM  
05:40AM  
Jan-09-20 04:27PM  
Jan-08-20 08:00AM  
Dec-24-19 12:00PM  
Dec-12-19 10:33AM  
Nov-27-19 03:23PM  
Nov-21-19 11:39AM  
Nov-18-19 05:34PM  
Nov-17-19 07:14AM  
Nov-12-19 04:01PM  
Nov-07-19 04:01PM  
Oct-31-19 04:01PM  
Oct-29-19 10:33AM  
Oct-25-19 07:12AM  
Oct-24-19 04:01PM  
Oct-17-19 09:46AM  
Oct-14-19 10:28AM  
Oct-11-19 11:46AM  
Oct-10-19 04:02PM  
Oct-09-19 07:58AM  
Oct-08-19 05:01PM  
01:42PM  
Oct-07-19 07:25AM  
Oct-06-19 10:00AM  
Oct-03-19 07:28AM  
Sep-30-19 12:15PM  
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel, small molecule therapeutics to address the needs of patients with immuno-inflammatory diseases. The company has a multi-stage portfolio of drug candidates powered by a research and development engine exploring protein kinase regulation. Its products pipeline includes ATI-450, an investigational oral, novel, small molecule selective MK2 inhibitor compound, which is being developed as a treatment for moderate to severe rheumatoid arthritis and additional immuno-inflammatory diseases; ATI-1777, an investigational topical soft JAK 1/3 inhibitor compound, which is being developed as a treatment for moderate to severe atopic dermatitis; and ATI-2138, an investigational oral ITK/TXK/JAK3 inhibitor compound, which is being developed as a treatment for psoriasis and/or inflammatory bowel disease. It also provides contract research services. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gordon David N.Chief Medical OfficerJul 13Sale16.982,63144,675147,447Jul 14 05:32 PM
Ali-Jackson KamilChief Legal OfficerJun 03Sale21.969,492208,421122,196Jun 04 07:52 PM
Monahan JosephChief Scientific OfficerJun 02Sale21.6421,790471,43785,342Jun 02 09:45 PM
Walker NealPresident and CEOJun 02Sale21.6433,260719,7351,232,182Jun 02 09:41 PM
Ali-Jackson KamilChief Legal OfficerJun 02Sale21.6430,119651,664131,688Jun 02 09:47 PM
Gordon David N.Chief Medical OfficerJun 02Sale21.6337,914820,209144,078Jun 02 09:49 PM
Gordon David N.Chief Medical OfficerJun 01Sale23.0114,000322,165181,992Jun 02 09:49 PM
Ali-Jackson KamilChief Legal OfficerJun 01Sale23.0215,000345,299161,807Jun 02 09:47 PM
Ali-Jackson KamilChief Legal OfficerMay 07Option Exercise10.665,41657,735149,034May 07 06:28 PM
Ali-Jackson KamilChief Legal OfficerMay 07Sale23.525,416127,392143,618May 07 06:28 PM
Ali-Jackson KamilChief Legal OfficerMay 06Option Exercise10.6615,000159,900158,618May 07 06:28 PM
Ali-Jackson KamilChief Legal OfficerMay 06Sale23.4315,000351,453143,618May 07 06:28 PM
Ali-Jackson KamilChief Legal OfficerMay 05Option Exercise10.6615,000159,900158,618May 05 08:04 PM
Ali-Jackson KamilChief Legal OfficerMay 05Sale23.9815,000359,713143,618May 05 08:04 PM
Ali-Jackson KamilChief Legal OfficerMay 04Option Exercise10.6615,000159,900158,618May 05 08:04 PM
Ali-Jackson KamilChief Legal OfficerMay 04Sale23.6815,000355,187143,618May 05 08:04 PM
Ali-Jackson KamilChief Legal OfficerMay 03Option Exercise10.6615,000159,900158,618May 05 08:04 PM
Ali-Jackson KamilChief Legal OfficerMay 03Sale24.5915,000368,818143,618May 05 08:04 PM
Ruffo FrankChief Financial OfficerApr 26Sale25.8027,339705,228151,720Apr 26 09:45 PM
Ruffo FrankChief Financial OfficerApr 23Sale26.6630,000799,660179,059Apr 26 09:45 PM
Ruffo FrankChief Financial OfficerApr 22Sale26.8430,000805,218209,059Apr 26 09:45 PM
Walker NealPresident and CEOApr 22Sale26.8430,000805,2391,192,427Apr 26 09:43 PM
Mehra AnandDirectorFeb 02Option Exercise18.3414,632268,29830,841Feb 03 05:33 PM
ADBE Adobe Inc. daily Stock Chart
ADBE [NASD]
Adobe Inc.
IndexS&P 500 P/E53.49 EPS (ttm)11.57 Insider Own0.10% Shs Outstand478.00M Perf Week-0.33%
Market Cap294.80B Forward P/E44.12 EPS next Y14.02 Insider Trans-16.42% Shs Float474.92M Perf Month5.82%
Income5.58B PEG2.90 EPS next Q3.01 Inst Own85.30% Short Float1.04% Perf Quarter22.90%
Sales14.39B P/S20.49 EPS this Y80.50% Inst Trans0.10% Short Ratio2.45 Perf Half Y31.65%
Book/sh28.98 P/B21.35 EPS next Y14.50% ROA23.00% Target Price618.99 Perf Year39.26%
Cash/sh12.11 P/C51.11 EPS next 5Y18.47% ROE42.60% 52W Range420.78 - 631.64 Perf YTD23.72%
Dividend- P/FCF44.70 EPS past 5Y54.30% ROI30.60% 52W High-2.04% Beta0.96
Dividend %- Quick Ratio1.30 Sales past 5Y21.80% Gross Margin87.90% 52W Low47.05% ATR9.50
Employees22516 Current Ratio1.30 Sales Q/Q22.60% Oper. Margin35.70% RSI (14)67.75 Volatility1.64% 1.60%
OptionableYes Debt/Eq0.00 EPS Q/Q2.30% Profit Margin38.80% Rel Volume0.71 Prev Close621.63
ShortableYes LT Debt/Eq0.30 EarningsJun 17 AMC Payout0.00%